← Back to Search

NA

Pears + Sweet Potatoes for Infant Development (IMiND Trial)

N/A
Waitlist Available
Led By Jennifer Smilowitz, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Term infants born >37 weeks gestation
Be between 18 and 65 years old
Must not have
Family history of immunodeficiency syndrome(s)
Infants with any GI tract abnormalities
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at how a baby's eating habits and gut health affect their development.

Who is the study for?
This trial is for mother-infant pairs near UC Davis, California. Infants must be born full-term and exclusively breastfed for at least 5 months, ready to start solids between 4-7.5 months old without any GI abnormalities or recent antibiotic use. Mothers should be healthy, aged 21-45, non-smokers, and willing to avoid giving infants formula or supplements during the study.
What is being tested?
The study investigates how introducing solid foods like pears and sweet potatoes to exclusively breastfed infants affects their gut microbiome and development. It tracks changes in fecal microbiota as these new foods are introduced and relates them to developmental milestones.
What are the potential side effects?
Since this trial involves common food items (pears and sweet potatoes) given to infants starting on solids, there aren't typical side effects like with medications; however, potential reactions could include normal digestive adjustments or food sensitivities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My baby was born after 37 weeks of pregnancy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My family has a history of immune system disorders.
Select...
My infant has a gastrointestinal (GI) tract abnormality.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of Adverse Events and Treatments
Infant fecal microbial diversity
Infant fecal microbiota composition
Secondary study objectives
Dietary composition
Fecal metabolomics
Glycosidic linkages
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sweet PotatosExperimental Treatment1 Intervention
Infants will consume commercially available baby food sweet potato (SP) (Plum Organics, Just Sweet Potato) for 7 days followed by a 4 day washout period of exclusive breast milk. Participants will be instructed to offer 1-2 tablespoons of sweet potato to their infant at least three times per day for seven days in a row.
Group II: PearsExperimental Treatment1 Intervention
Infants will consume commercially available baby food pear (P) (Earth's Best, First Pears) for 7 days followed by a 4 day washout period of exclusive breast milk. Participants will be instructed to offer 1-2 tablespoons of pears to their infant at least three times per day for seven days in a row.

Find a Location

Who is running the clinical trial?

UC Davis Foods for Health InstituteUNKNOWN
Mengniu DairyUNKNOWN
University of California, DavisLead Sponsor
945 Previous Clinical Trials
4,756,038 Total Patients Enrolled
1 Trials studying Infant Development
8 Patients Enrolled for Infant Development
Jennifer Smilowitz, PhDPrincipal InvestigatorUniversity of California, Davis
5 Previous Clinical Trials
220 Total Patients Enrolled
Lisa Oakes, PhDPrincipal InvestigatorUniversity of California, Davis

Media Library

Pears (NA) Clinical Trial Eligibility Overview. Trial Name: NCT03229863 — N/A
Infant Development Research Study Groups: Sweet Potatos, Pears
Infant Development Clinical Trial 2023: Pears Highlights & Side Effects. Trial Name: NCT03229863 — N/A
Pears (NA) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03229863 — N/A
~12 spots leftby Dec 2025